February 2022

Mayeta Clark 2015

Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development

February 15, 2022

The emergence and spread of parasite resistance to currently available antimalarials has highlighted the importance of developing novel antimalarials. This…

Read More

Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens

February 2, 2022

Investigation of the diversity of malaria parasite antigens can help prioritize and validate them as vaccine candidates and identify the…

Read More

Tafenoquine for children: a step towards implementation

February 1, 2022

After several decades of development, tafenoquine, an 8-aminoquinoline compound, was registered by the US Food and Drug Administration on July…

Read More